📅 19th - 20th June 2025 📍 Heathrow, London
Merck Serono Ltd
Merck is a science-led organisation dedicated to delivering transformative medicines with the goal of making a meaningful difference in the lives of people affected by cancer. Our pioneering spirit drives us to help address this need by discovering and delivering innovative approaches to cancer care.
We are harnessing this spirit and our strength as a global pharmaceutical company to invest significant resources into our research and development, which is demonstrated through our rapidly evolving pipeline of potential new cancer treatments.
But we know we cannot do this alone and endeavour to accelerate innovation by partnering with some of the leading minds in the cancer community—from industry to academic institutions to leading cancer centres, to pursue integrated innovations that might have the potential to transform cancer care.
Our oncology research efforts aim to leverage our synergistic portfolio to tackle challenging tumour types in gastrointestinal, genitourinary, and thoracic cancers.
Learn more at https://www.merckgroup.com/uk-en